

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candi...
Q2 2026
Sep 14, 2026
Q1 2026
May 25, 2026
FY 2025
Mar 23, 2026
Q4 2025
Mar 23, 2026
Q3 2025
Dec 15, 2025